Search results for "controlled"

showing 10 items of 2729 documents

A noninvasive postoperative clinical score to identify patients at risk for postoperative pulmonary complications: The air-test score

2020

BACKGROUND: Postoperative pulmonary complications (PPCs) negatively affect morbidity, healthcare costs and postsurgical survival. Preoperative and intraoperative peripheral oxyhemoglobin saturation (SpO2) levels are independent risk factors for postoperative pulmonary complications (PPCs). The air-test assesses the value of SpO2 while breathing room-air. We aimed at building a clinical score that includes the air-test for predicting the risk for PPCs. METHODS: This is a development and validation study in patients -randomly divided into two cohorts- from a large randomized clinical trial (iPROVE) that enrolled 964 intermediate-to-high risk patients scheduled for abdominal surgery. Arterial …

medicine.medical_specialtyValidation studyPulmonary AtelectasisAtelectasisRisk Assessmentlaw.inventionCohort Studies03 medical and health sciencesPostoperative pulmonary atelectasis0302 clinical medicinePostoperative ComplicationsRandomized controlled trial030202 anesthesiologylawRisk FactorsmedicineHumansPredictive value of testDerivationLungReceiver operating characteristicbusiness.industryfungi030208 emergency & critical care medicinemedicine.diseaseSurgeryRespiratory Function TestsPostoperative complicationAnesthesiology and Pain MedicineTest scoreCohortbusinessAbdominal surgery
researchProduct

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis

1994

Between 1988 and 1990 an unblinded, randomized trial of terlipressin or vasopressin plus transdermal nitroglycerin, as part of a treatment strategy including emergency sclerotherapy for actively bleeding varices, was conducted during 165 admissions in 137 patients with cirrhosis and upper digestive bleeding. Eighty-four patient admissions were assigned to terlipressin (2 mg every 6 h) and 81 to vasopressin (0.4 to 0.8 unit per min) plus transdermal nitroglycerin (20 to 80 mg). The two groups were comparable for relevant clinical data, but there were slightly more patients with hepatocellular carcinoma or terminal conditions in the terlipressin group. After the 24-h study period, failure to …

medicine.medical_specialtyVasopressinCirrhosisHepatologybusiness.industrymedicine.medical_treatmentmedicine.diseaseSurgerylaw.inventionDiscontinuationRandomized controlled triallawAnesthesiamedicineSclerotherapyUpper gastrointestinal bleedingbusinessTerlipressinVaricesmedicine.drugJournal of Hepatology
researchProduct

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism

2020

Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those withou…

medicine.medical_specialtyVena Cava FiltersDeep vein01 natural sciencesPostthrombotic Syndromelaw.inventionFibrin Fibrinogen Degradation Products03 medical and health sciencesSex Factors0302 clinical medicineRandomized controlled trialPredictive Value of TestsRisk FactorslawInternal medicineMedical IllustrationFactor V LeidenHumansThrombophiliaMedicineCumulative incidencecardiovascular diseases030212 general & internal medicine0101 mathematicsLife StyleThrombectomyUltrasonographybusiness.industry010102 general mathematicsAge FactorsWarfarinVenous ThromboembolismGeneral Medicinemedicine.diseaseThrombosisPre- and post-test probabilitymedicine.anatomical_structureLower ExtremityPredictive value of testsWarfarinSymptom AssessmentbusinessBiomarkersFactor Xa Inhibitorsmedicine.drugJAMA
researchProduct

Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature

2013

Abstract: It remains unclear which liver graft reperfusion technique leads to the best outcome following transplantation. An online survey was sent to all transplant centres (n=37) within Eurotransplant (ET) to collect information on their technique used for reperfusion of liver grafts. Furthermore, a systematic review of all literature was performed and a meta-analysis was conducted based on patients' mortality, number of retransplantations and incidence of biliary complications, depending on the technique used. Of the 28 evaluated centres, 11 (39%) reported performing simultaneous reperfusion (SIMR), 13 (46%) perform initial portal vein reperfusion (IPR), 1 (4%) performs an initial hepati…

medicine.medical_specialtyVena cavamedicine.medical_treatmentPortal veinMedizin030230 surgeryRevascularizationVenovenous bypassretrograde reperfusionlaw.invention03 medical and health sciences0302 clinical medicineHepatic ArteryRandomized controlled triallawSurveys and QuestionnairesMedicineHumansRandomized Controlled Trials as TopicTransplantationbusiness.industryPortal Veinsimultaneous reperfusion3. Good healthSurgeryLiver TransplantationTransplantationLiver graftEuropeTreatment OutcomeMeta-analysisReperfusion030211 gastroenterology & hepatologyHuman medicineliver reperfusionbusinesssequential reperfusionLiver Circulation
researchProduct

Mitigando el dolor durante la punción venosa en una población pediátrica: un estudio factorial aleatorizado

2016

medicine.medical_specialtyVenipuncturebusiness.industryMEDLINEGeneral MedicineFactorial experimentPhlebotomylaw.inventionProcedural Pain03 medical and health sciences0302 clinical medicineRandomized controlled triallawPhysical therapymedicine030212 general & internal medicinebusiness030217 neurology & neurosurgeryGeneral NursingPediatric populationEnfermería Clínica
researchProduct

Intravitreal Dexamethasone Implant for Postoperative Macular Oedema Secondary to Vitrectomy for Epiretinal Membrane and Retinal Detachment: A Systema…

2021

Purpose. To evaluate the efficacy of intravitreal dexamethasone implant (DEX) for the treatment of macular oedema secondary to vitrectomy for epiretinal membrane (ERM) and retinal detachment (RD) by conducting a systematic review with meta-analysis of published studies. Methods. Studies reporting clinical outcomes of DEX use for the treatment of macular oedema secondary to ERM and RD vitrectomy were searched on PubMed and Embase databases. The primary outcome was best-corrected visual acuity (BCVA) change between baseline and post-DEX treatment, reported as mean difference (MD) with 95% confidence interval (CI). Mean central macular thickness (CMT) change was assessed as a secondary outcome…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentPopulationVitrectomyReview Articlelaw.inventionRandomized controlled triallawOphthalmologymedicineeducationDexamethasoneeducation.field_of_studybusiness.industryRetinal detachmentRE1-994medicine.diseaseConfidence intervalmacular oedema intravitreal dexamethasone implant (DEX) vitrectomy epiretinal membrane (ERM) retinal detachment (RD).OphthalmologyEpiretinal membranemedicine.symptombusinessmedicine.drug
researchProduct

Efficacy of the photobiomodulation therapy in the treatment of the burning mouth syndrome

2019

Background This study aims to evaluate the efficacy of the photobiomodulation therapy (PBMT) - in terms of pain and of quality of life- in patients affected by burning mouth syndrome (BMS). Material and Methods This study was designed as a randomised double-blinded prospective study. Patients diagnosed with BMS in the period from June 2015 to June 2018 were recruited. The patients were randomised into two groups and each received treatment once a week for ten weeks: group A received laser therapy (K Laser Cube 3®) while group B was given sham therapy (placebo). Pain was evaluated through the Visual Analogue Scale (VAS) and quality of life was assessed with the short form of the Oral Health …

medicine.medical_specialtyVisual analogue scaleBurning Mouth SyndromeOral healthPlaceboGroup Blaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifelawSurveys and QuestionnairesInternal medicineHumansMedicineProspective StudiesLow-Level Light TherapyProspective cohort studyGeneral DentistryOral Medicine and Pathologybusiness.industryResearch030206 dentistryBurning mouth syndrome:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeSurgerymedicine.symptombusiness
researchProduct

Photobiomodulation therapy for the management of recurrent aphthous stomatitis in children : clinical effectiveness and parental satisfaction

2020

Background This study aims to evaluate the effectiveness of the photobiomodulation therapy (PBMT) in the treatment of minor recurrent aphthous stomatitis (MiRAS) in children, in terms of pain relief, lesion size reduction and the parental satisfaction of the therapy. Material and Methods This randomized controlled study was carried out on 60 children with clinical diagnosis of MiRAS. Patients were randomized into two groups: group A receiving laser therapy and group B receiving sham therapy (placebo). Laser therapy (diode laser, λ: 645 nm) was administered on day 1 (T0) for three consecutive days. Patients were evaluated also on day 4 (T1), on day 7 (T2) and on day 10 (T3). Oral aphthous le…

medicine.medical_specialtyVisual analogue scaleChildren; Lasers; UlcersPersonal SatisfactionPlaceboRecurrent aphthous stomatitisPeriodontal probeGroup Blaw.inventionLesion03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansLow-Level Light TherapyChildChildrenGeneral DentistryStomatitisPain MeasurementUlcersOral Medicine and Pathologybusiness.industryResearchLasers030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Treatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASStomatitis AphthousSurgerymedicine.symptombusiness
researchProduct

Local Formula with Mucoadhesive Property: A Randomized Clinical Trial of a Therapeutic Agent for the Treatment of Oral Aphthous Ulcers

2020

Background Recurrent or occasional aphthous lesions represent a painful oral condition with high prevalence. Since the etiology is still unclear and most likely related to a dysfunction in the local immune system, several treatment strategies have been proposed, including systemic agents, local agents, and laser therapy, to reduce the pain and discomfort for the patient without acting on the causes. Materials and methods The purpose of the present randomized study was to assess the clinical efficacy of a new topical gel with mucoadhesive property to reduce the pain and the dimension of the aphthosis lesions. Fifty patients presenting at least one minor ulcer were randomized to a control gro…

medicine.medical_specialtyVisual analogue scalePainPlacebolaw.invention03 medical and health sciencesOral aphthous ulcers0302 clinical medicineRandomized controlled triallawAdjuvant therapyHumansMedicineClinical significanceMedical prescriptionGeneral DentistryWound Healingbusiness.industry030206 dentistryDermatologyTreatment Outcome030220 oncology & carcinogenesisEtiologyStomatitis AphthousbusinessGelsThe Journal of Contemporary Dental Practice
researchProduct

Antivitamin K Drugs in Stroke Prevention

2014

Among the different subtypes of ischaemic strokes, almost 20 % are of cardiac origin. Different are the causes of cardioembolic stroke, but the most common is the atrial fibrillation, a supraventricular arrhythmia. Appropriate use of antiplatelet drugs and anticoagulants after transient ischaemic attack (TIA) or ischaemic stroke depends on whether the underlying cause is cardioembolic or of presumed arterial origin. Adequate antiplatelet therapy is recommended for secondary prevention after cerebral ischaemia of presumed arterial origin, whether for patients with TIA and ischaemic stroke of cardiac origin, mainly due to atrial fibrillation. Vitamin K antagonists (VKAs) are highly effective …

medicine.medical_specialtyVitamin KSettore MED/09 - Medicina InternaAppropriate useInternal medicinemedicineAnimalsHumanscardiovascular diseasesRandomized Controlled Trials as TopicPharmacologySupraventricular arrhythmiabusiness.industryPatient choiceStandard treatmentAnticoagulantsVKAs Stroke preventionAtrial fibrillationmedicine.diseaseStrokeIschemic Attack TransientStroke preventionCardiologyCerebral ischaemiaCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsDiscovery and development of direct thrombin inhibitorsCurrent Vascular Pharmacology
researchProduct